CNY243.00
0.75% today
Shanghai, Aug 18, 09:00 am CET
ISIN
CH1391448177
Symbol
688235

BeOne Medicines Target price 2025 - Analyst rating & recommendation

BeOne Medicines Classifications & Recommendation:

Buy
93%
Hold
7%

BeOne Medicines Price Target

Target Price CNY300.99
Price CNY243.00
Potential
Number of Estimates 8
8 Analysts have issued a price target BeOne Medicines 2026 . The average BeOne Medicines target price is CNY300.99. This is higher than the current stock price. The highest price target is
CNY366.35 50.76%
register free of charge
, the lowest is
CNY275.73 13.47%
register free of charge
.
A rating was issued by 14 analysts: 13 Analysts recommend BeOne Medicines to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BeOne Medicines stock has an average upside potential 2026 of . Most analysts recommend the BeOne Medicines stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion CNY 27.21 36.78
56.19% 35.14%
EBITDA Margin -13.43% 4.74%
72.09% 135.28%
Net Margin -18.29% 1.33%
52.54% 107.27%

9 Analysts have issued a sales forecast BeOne Medicines 2025 . The average BeOne Medicines sales estimate is

CNY36.8b
Unlock
. This is
22.99% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CNY39.2b 31.22%
Unlock
, the lowest is
CNY35.1b 17.52%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 CNY27.2b 56.19%
2025
CNY36.8b 35.14%
Unlock
2026
CNY44.5b 21.12%
Unlock
2027
CNY51.3b 15.26%
Unlock
2028
CNY58.0b 13.00%
Unlock
2029
CNY64.2b 10.68%
Unlock
2030
CNY71.1b 10.72%
Unlock
2031
CNY75.9b 6.74%
Unlock
2032
CNY79.2b 4.38%
Unlock

7 BeOne Medicines Analysts have issued a net profit forecast 2025. The average BeOne Medicines net profit estimate is

CNY488m
Unlock
. This is
115.41% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CNY1.3b 140.36%
Unlock
, the lowest is
CNY137m 104.34%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 CNY-5.0b 25.87%
2025
CNY488m 109.80%
Unlock
2026
CNY3.6b 641.69%
Unlock
2027
CNY7.4b 103.25%
Unlock
2028
CNY116b 1,482.43%
Unlock
2029
CNY132b 13.42%
Unlock
2030
CNY175b 32.82%
Unlock
2031
CNY162b 7.76%
Unlock
2032
CNY217b 34.21%
Unlock

Net Margin

2024 -18.29% 52.54%
2025
1.33% 107.27%
Unlock
2026
8.12% 510.53%
Unlock
2027
14.32% 76.35%
Unlock
2028
200.58% 1,300.70%
Unlock
2029
205.55% 2.48%
Unlock
2030
246.57% 19.96%
Unlock
2031
213.08% 13.58%
Unlock
2032
273.96% 28.57%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share CNY -3.64 0.35
26.46% 109.62%
P/E 693.71
EV/Sales 7.02

7 Analysts have issued a BeOne Medicines forecast for earnings per share. The average BeOne Medicines EPS is

CNY0.35
Unlock
. This is
114.96% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
CNY0.91 138.89%
Unlock
, the lowest is
CNY0.10 104.27%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CNY-3.64 26.46%
2025
CNY0.35 109.62%
Unlock
2026
CNY2.58 637.14%
Unlock
2027
CNY5.24 103.10%
Unlock
2028
CNY82.94 1,482.82%
Unlock
2029
CNY94.07 13.42%
Unlock
2030
CNY124.95 32.83%
Unlock
2031
CNY115.25 7.76%
Unlock
2032
CNY154.68 34.21%
Unlock

P/E ratio

Current -103.07 136.31%
2025
693.71 773.03%
Unlock
2026
93.53 86.52%
Unlock
2027
46.02 50.80%
Unlock
2028
2.91 93.68%
Unlock
2029
2.56 12.03%
Unlock
2030
1.93 24.61%
Unlock
2031
2.09 8.29%
Unlock
2032
1.56 25.36%
Unlock

Based on analysts' sales estimates for 2025, the BeOne Medicines stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.64 44.48%
2025
7.02 18.73%
Unlock
2026
5.80 17.44%
Unlock
2027
5.03 13.24%
Unlock
2028
4.45 11.50%
Unlock
2029
4.02 9.65%
Unlock
2030
3.63 9.68%
Unlock
2031
3.40 6.32%
Unlock
2032
3.26 4.20%
Unlock

P/S ratio

Current 8.98 38.73%
2025
7.30 18.69%
Unlock
2026
6.03 17.44%
Unlock
2027
5.23 13.24%
Unlock
2028
4.63 11.50%
Unlock
2029
4.18 9.65%
Unlock
2030
3.78 9.68%
Unlock
2031
3.54 6.32%
Unlock
2032
3.39 4.20%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today